Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

UG vs CBT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
UG
United-Guardian, Inc.

Household & Personal Products

Consumer DefensiveNASDAQ • US
Market Cap$32M
5Y Perf.-55.6%
CBT
Cabot Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$4.24B
5Y Perf.+127.5%

UG vs CBT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
UG logoUG
CBT logoCBT
IndustryHousehold & Personal ProductsChemicals - Specialty
Market Cap$32M$4.24B
Revenue (TTM)$11M$3.58B
Net Income (TTM)$2M$285M
Gross Margin47.7%24.8%
Operating Margin21.3%15.7%
Forward P/E15.2x13.0x
Total Debt$0.00$1.22B
Cash & Equiv.$1M$258M

UG vs CBTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

UG
CBT
StockMay 20May 26Return
United-Guardian, In… (UG)10044.4-55.6%
Cabot Corporation (CBT)100227.5+127.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: UG vs CBT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UG leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Cabot Corporation is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
UG
United-Guardian, Inc.
The Income Pick

UG carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 2 yrs, beta 0.33, yield 8.6%
  • Lower volatility, beta 0.33, current ratio 7.31x
  • Beta 0.33, yield 8.6%, current ratio 7.31x
Best for: income & stability and sleep-well-at-night
CBT
Cabot Corporation
The Growth Play

CBT is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth -7.0%, EPS growth -10.4%, 3Y rev CAGR -4.9%
  • 115.7% 10Y total return vs UG's -12.1%
  • -7.0% revenue growth vs UG's -13.4%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCBT logoCBT-7.0% revenue growth vs UG's -13.4%
ValueCBT logoCBTLower P/E (13.0x vs 15.2x)
Quality / MarginsUG logoUG20.0% margin vs CBT's 8.0%
Stability / SafetyUG logoUGBeta 0.33 vs CBT's 0.78
DividendsUG logoUG8.6% yield, 2-year raise streak, vs CBT's 2.2%
Momentum (1Y)CBT logoCBT+13.8% vs UG's -6.0%
Efficiency (ROA)UG logoUG16.3% ROA vs CBT's 7.4%, ROIC 16.8% vs 17.4%

UG vs CBT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

UGUnited-Guardian, Inc.
FY 2016
Personal Care
44.1%$5M
Pharmaceuticals
30.9%$3M
Medical
23.6%$3M
Industrial And Other
1.4%$159,945
CBTCabot Corporation
FY 2025
Reinforcement Materials
65.2%$2.3B
Performance Chemicals
34.8%$1.3B

UG vs CBT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUGLAGGINGCBT

Income & Cash Flow (Last 12 Months)

UG leads this category, winning 6 of 6 comparable metrics.

CBT is the larger business by revenue, generating $3.6B annually — 339.0x UG's $11M. UG is the more profitable business, keeping 20.0% of every revenue dollar as net income compared to CBT's 8.0%. On growth, UG holds the edge at +19.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricUG logoUGUnited-Guardian, …CBT logoCBTCabot Corporation
RevenueTrailing 12 months$11M$3.6B
EBITDAEarnings before interest/tax$2M$731M
Net IncomeAfter-tax profit$2M$285M
Free Cash FlowCash after capex$2M$459M
Gross MarginGross profit ÷ Revenue+47.7%+24.8%
Operating MarginEBIT ÷ Revenue+21.3%+15.7%
Net MarginNet income ÷ Revenue+20.0%+8.0%
FCF MarginFCF ÷ Revenue+18.1%+12.8%
Rev. Growth (YoY)Latest quarter vs prior year+19.6%-3.4%
EPS Growth (YoY)Latest quarter vs prior year+27.3%-23.1%
UG leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

CBT leads this category, winning 5 of 5 comparable metrics.

At 13.5x trailing earnings, CBT trades at a 11% valuation discount to UG's 15.2x P/E. On an enterprise value basis, CBT's 6.7x EV/EBITDA is more attractive than UG's 13.1x.

MetricUG logoUGUnited-Guardian, …CBT logoCBTCabot Corporation
Market CapShares × price$32M$4.2B
Enterprise ValueMkt cap + debt − cash$31M$5.2B
Trailing P/EPrice ÷ TTM EPS15.22x13.50x
Forward P/EPrice ÷ next-FY EPS est.13.04x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple13.14x6.71x
Price / SalesMarket cap ÷ Revenue3.05x1.14x
Price / BookPrice ÷ Book value/share2.86x2.58x
Price / FCFMarket cap ÷ FCF16.86x10.86x
CBT leads this category, winning 5 of 5 comparable metrics.

Profitability & Efficiency

UG leads this category, winning 4 of 7 comparable metrics.

UG delivers a 19.1% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $17 for CBT. On the Piotroski fundamental quality scale (0–9), CBT scores 6/9 vs UG's 4/9, reflecting solid financial health.

MetricUG logoUGUnited-Guardian, …CBT logoCBTCabot Corporation
ROE (TTM)Return on equity+19.1%+16.8%
ROA (TTM)Return on assets+16.3%+7.4%
ROICReturn on invested capital+16.8%+17.4%
ROCEReturn on capital employed+18.9%+21.3%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.71x
Net DebtTotal debt minus cash-$1M$957M
Cash & Equiv.Liquid assets$1M$258M
Total DebtShort + long-term debt$0$1.2B
Interest CoverageEBIT ÷ Interest expense14.72x
UG leads this category, winning 4 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

CBT leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CBT five years ago would be worth $14,321 today (with dividends reinvested), compared to $7,000 for UG. Over the past 12 months, CBT leads with a +13.8% total return vs UG's -6.0%. The 3-year compound annual growth rate (CAGR) favors CBT at 7.0% vs UG's -5.4% — a key indicator of consistent wealth creation.

MetricUG logoUGUnited-Guardian, …CBT logoCBTCabot Corporation
YTD ReturnYear-to-date+18.3%+21.9%
1-Year ReturnPast 12 months-6.0%+13.8%
3-Year ReturnCumulative with dividends-15.4%+22.5%
5-Year ReturnCumulative with dividends-30.0%+43.2%
10-Year ReturnCumulative with dividends-12.1%+115.7%
CAGR (3Y)Annualised 3-year return-5.4%+7.0%
CBT leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — UG and CBT each lead in 1 of 2 comparable metrics.

UG is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than CBT's 0.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 96.1% from its 52-week high vs UG's 70.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricUG logoUGUnited-Guardian, …CBT logoCBTCabot Corporation
Beta (5Y)Sensitivity to S&P 5000.33x0.78x
52-Week HighHighest price in past year$9.88$84.60
52-Week LowLowest price in past year$5.58$58.33
% of 52W HighCurrent price vs 52-week peak+70.9%+96.1%
RSI (14)Momentum oscillator 0–10046.271.7
Avg Volume (50D)Average daily shares traded4K374K
Evenly matched — UG and CBT each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — UG and CBT each lead in 1 of 2 comparable metrics.

For income investors, UG offers the higher dividend yield at 8.60% vs CBT's 2.18%.

MetricUG logoUGUnited-Guardian, …CBT logoCBTCabot Corporation
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$78.00
# AnalystsCovering analysts15
Dividend YieldAnnual dividend ÷ price+8.6%+2.2%
Dividend StreakConsecutive years of raises24
Dividend / ShareAnnual DPS$0.60$1.77
Buyback YieldShare repurchases ÷ mkt cap0.0%+4.0%
Evenly matched — UG and CBT each lead in 1 of 2 comparable metrics.
Key Takeaway

UG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CBT leads in 2 (Valuation Metrics, Total Returns). 2 tied.

Best OverallUnited-Guardian, Inc. (UG)Leads 2 of 6 categories
Loading custom metrics...

UG vs CBT: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is UG or CBT a better buy right now?

For growth investors, Cabot Corporation (CBT) is the stronger pick with -7.

0% revenue growth year-over-year, versus -13. 4% for United-Guardian, Inc. (UG). Cabot Corporation (CBT) offers the better valuation at 13. 5x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Cabot Corporation (CBT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — UG or CBT?

On trailing P/E, Cabot Corporation (CBT) is the cheapest at 13.

5x versus United-Guardian, Inc. at 15. 2x.

03

Which is the better long-term investment — UG or CBT?

Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +43.

2%, compared to -30. 0% for United-Guardian, Inc. (UG). Over 10 years, the gap is even starker: CBT returned +115. 7% versus UG's -12. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — UG or CBT?

By beta (market sensitivity over 5 years), United-Guardian, Inc.

(UG) is the lower-risk stock at 0. 33β versus Cabot Corporation's 0. 78β — meaning CBT is approximately 136% more volatile than UG relative to the S&P 500.

05

Which is growing faster — UG or CBT?

By revenue growth (latest reported year), Cabot Corporation (CBT) is pulling ahead at -7.

0% versus -13. 4% for United-Guardian, Inc. (UG). On earnings-per-share growth, the picture is similar: Cabot Corporation grew EPS -10. 4% year-over-year, compared to -35. 2% for United-Guardian, Inc.. Over a 3-year CAGR, CBT leads at -4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — UG or CBT?

United-Guardian, Inc.

(UG) is the more profitable company, earning 20. 0% net margin versus 8. 9% for Cabot Corporation — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UG leads at 21. 3% versus 16. 7% for CBT. At the gross margin level — before operating expenses — UG leads at 47. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Which pays a better dividend — UG or CBT?

All stocks in this comparison pay dividends.

United-Guardian, Inc. (UG) offers the highest yield at 8. 6%, versus 2. 2% for Cabot Corporation (CBT).

08

Is UG or CBT better for a retirement portfolio?

For long-horizon retirement investors, United-Guardian, Inc.

(UG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 33), 8. 6% yield). Both have compounded well over 10 years (UG: -12. 1%, CBT: +115. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between UG and CBT?

These companies operate in different sectors (UG (Consumer Defensive) and CBT (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

UG

High-Growth Compounder

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 11%
Run This Screen
Stocks Like

CBT

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform UG and CBT on the metrics below

Revenue Growth>
%
(UG: 19.6% · CBT: -3.4%)
Net Margin>
%
(UG: 20.0% · CBT: 8.0%)
P/E Ratio<
x
(UG: 15.2x · CBT: 13.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.